You have 9 free searches left this month | for more free features.

Meibomitis

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HMG-CoA Reductase Inhibitors on Meibomian Gland Morphology in

Completed
  • Meibomian Gland Dysfunction
  • +2 more
  • Keratograph 5M, Oculus, Wetzlar, Germany
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 12, 2020

Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses, Ocular Surface Disease Trial in Boston (Maskin Probe)

Recruiting
  • Stevens-Johnson Syndrome
  • +5 more
  • Maskin Probe
  • Boston, Massachusetts
    Massachusetts Eye and Ear Hospital
Nov 23, 2021

Meibomian Gland Dysfunction Trial in Andover (testosterone ophthalmic solution, vehicle of testosterone ophthalmic solution)

Completed
  • Meibomian Gland Dysfunction
  • testosterone ophthalmic solution
  • vehicle of testosterone ophthalmic solution
  • Andover, Massachusetts
    Ophthalmic Research Associates
Sep 29, 2020

Clinical, Meibographic and Interferometric Evaluation of

Completed
  • Ocular Rosacea
  • +2 more
  • Ophthalmologic examination and meibographic and interferometric evaluation (Lipiview device)
  • Paris, France
    Fondation Ophtalmologique A. de Rothschild
May 12, 2020

Dry Eye, Neuropathic Eye Pain, Ocular Microbiome Trial in San Francisco (Azithromycin Oral Product, Placebo Oral)

Recruiting
  • Dry Eye
  • +3 more
  • Azithromycin Oral Product
  • Placebo Oral
  • San Francisco, California
    University of California San Francisco
Jan 29, 2021

Bronchiolitis Obliterans Trial in Chicago (Bortezomib)

Terminated
  • Bronchiolitis Obliterans
  • Chicago, Illinois
    Northwestern University
Apr 8, 2020

Patients With Corneal and External Diseases

Completed
  • Blepharitis
  • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 30, 2017

    Ocular Tolerance, Skin Tolerance Trial in Sao Paulo (Systane® Lid Wipes)

    Completed
    • Ocular Tolerance
    • Skin Tolerance
    • Systane® Lid Wipes
    • Sao Paulo, Brazil
      Novartis Biociencias SA
    Sep 29, 2016